Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa

Nicholas Musinguzi, Collins D. Muganzi, Yap Boum, Allan Ronald, Mark A. Marzinke, Craig W. Hendrix, Connie Celum, Jared M. Baeten, David Bangsberg, Jessica E. Haberer

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background: Preexposure prophylaxis (PrEP) efficacy is highly dependent on adherence. Yet, it is unclear which adherence measures perform best for PrEP. Methods: We compared three types of self-reported adherence questions (rating of ability to adhere, frequency of doses taken, percentage of doses taken) and three forms of objective adherence measurement [unannounced pill counts (UPC), electronic monitoring, plasma tenofovir levels] using data from an ancillary adherence study within a clinical trial of PrEP among East African serodiscordant couples (Partners PrEP Study). Monthly measures were assessed for the first 6 months of follow-up. Results: One thousand, one hundred and forty-seven participants contributed 6048 person-months of data to this analysis. Median adherence was high: self-reported rating (90%), self-reported frequency (93%), and self-reported percentage (97%); UPC (99%); and electronic monitoring (97%). Prevalence of steady-state daily dosing (SSDD; ≥40ng/ml) was 74% in a random subset of tenofovir samples obtained from 365 participants. Discrimination of SSDD versus less than SSDD levels was poor for self-reported rating [area under the receiver-operating curve (AROC) 0.54], self-reported frequency (AROC 0.52), self-reported percentage (AROC 0.56) and UPC (AROC 0.58), but moderate for electronic monitoring (AROC 0.70). Correlation was moderate among self-reported measures, adherence (0.61-0.66), but low for these self-reported measures compared with UPC (0.32-0.36) and with electronic monitoring (0.22-0.28). Conclusion: Electronic monitoring was the only adherence measure with meaningful ability to discriminate between SSDD and less than SSDD plasma tenofovir levels. Correlation between subjective and objective measures was poor. Future research should explore novel approaches to adherence measurement as PrEP moves into demonstration projects and programmatic implementation.

Original languageEnglish (US)
Pages (from-to)1121-1129
Number of pages9
JournalAIDS
Volume30
Issue number7
DOIs
StatePublished - Apr 24 2016
Externally publishedYes

Fingerprint

Tenofovir
Eastern Africa
HIV Infections
Clinical Trials

Keywords

  • adherence
  • drug levels
  • East Africa
  • objective adherence
  • preexposure prophylaxis
  • serodiscordant
  • subjective adherence
  • tenofovir

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Cite this

Musinguzi, N., Muganzi, C. D., Boum, Y., Ronald, A., Marzinke, M. A., Hendrix, C. W., ... Haberer, J. E. (2016). Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. AIDS, 30(7), 1121-1129. https://doi.org/10.1097/QAD.0000000000001024

Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. / Musinguzi, Nicholas; Muganzi, Collins D.; Boum, Yap; Ronald, Allan; Marzinke, Mark A.; Hendrix, Craig W.; Celum, Connie; Baeten, Jared M.; Bangsberg, David; Haberer, Jessica E.

In: AIDS, Vol. 30, No. 7, 24.04.2016, p. 1121-1129.

Research output: Contribution to journalArticle

Musinguzi, N, Muganzi, CD, Boum, Y, Ronald, A, Marzinke, MA, Hendrix, CW, Celum, C, Baeten, JM, Bangsberg, D & Haberer, JE 2016, 'Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa', AIDS, vol. 30, no. 7, pp. 1121-1129. https://doi.org/10.1097/QAD.0000000000001024
Musinguzi, Nicholas ; Muganzi, Collins D. ; Boum, Yap ; Ronald, Allan ; Marzinke, Mark A. ; Hendrix, Craig W. ; Celum, Connie ; Baeten, Jared M. ; Bangsberg, David ; Haberer, Jessica E. / Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa. In: AIDS. 2016 ; Vol. 30, No. 7. pp. 1121-1129.
@article{a98ef289635e401e9fcbfcd7f591cc39,
title = "Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa",
abstract = "Background: Preexposure prophylaxis (PrEP) efficacy is highly dependent on adherence. Yet, it is unclear which adherence measures perform best for PrEP. Methods: We compared three types of self-reported adherence questions (rating of ability to adhere, frequency of doses taken, percentage of doses taken) and three forms of objective adherence measurement [unannounced pill counts (UPC), electronic monitoring, plasma tenofovir levels] using data from an ancillary adherence study within a clinical trial of PrEP among East African serodiscordant couples (Partners PrEP Study). Monthly measures were assessed for the first 6 months of follow-up. Results: One thousand, one hundred and forty-seven participants contributed 6048 person-months of data to this analysis. Median adherence was high: self-reported rating (90{\%}), self-reported frequency (93{\%}), and self-reported percentage (97{\%}); UPC (99{\%}); and electronic monitoring (97{\%}). Prevalence of steady-state daily dosing (SSDD; ≥40ng/ml) was 74{\%} in a random subset of tenofovir samples obtained from 365 participants. Discrimination of SSDD versus less than SSDD levels was poor for self-reported rating [area under the receiver-operating curve (AROC) 0.54], self-reported frequency (AROC 0.52), self-reported percentage (AROC 0.56) and UPC (AROC 0.58), but moderate for electronic monitoring (AROC 0.70). Correlation was moderate among self-reported measures, adherence (0.61-0.66), but low for these self-reported measures compared with UPC (0.32-0.36) and with electronic monitoring (0.22-0.28). Conclusion: Electronic monitoring was the only adherence measure with meaningful ability to discriminate between SSDD and less than SSDD plasma tenofovir levels. Correlation between subjective and objective measures was poor. Future research should explore novel approaches to adherence measurement as PrEP moves into demonstration projects and programmatic implementation.",
keywords = "adherence, drug levels, East Africa, objective adherence, preexposure prophylaxis, serodiscordant, subjective adherence, tenofovir",
author = "Nicholas Musinguzi and Muganzi, {Collins D.} and Yap Boum and Allan Ronald and Marzinke, {Mark A.} and Hendrix, {Craig W.} and Connie Celum and Baeten, {Jared M.} and David Bangsberg and Haberer, {Jessica E.}",
year = "2016",
month = "4",
day = "24",
doi = "10.1097/QAD.0000000000001024",
language = "English (US)",
volume = "30",
pages = "1121--1129",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Comparison of subjective and objective adherence measures for preexposure prophylaxis against HIV infection among serodiscordant couples in East Africa

AU - Musinguzi, Nicholas

AU - Muganzi, Collins D.

AU - Boum, Yap

AU - Ronald, Allan

AU - Marzinke, Mark A.

AU - Hendrix, Craig W.

AU - Celum, Connie

AU - Baeten, Jared M.

AU - Bangsberg, David

AU - Haberer, Jessica E.

PY - 2016/4/24

Y1 - 2016/4/24

N2 - Background: Preexposure prophylaxis (PrEP) efficacy is highly dependent on adherence. Yet, it is unclear which adherence measures perform best for PrEP. Methods: We compared three types of self-reported adherence questions (rating of ability to adhere, frequency of doses taken, percentage of doses taken) and three forms of objective adherence measurement [unannounced pill counts (UPC), electronic monitoring, plasma tenofovir levels] using data from an ancillary adherence study within a clinical trial of PrEP among East African serodiscordant couples (Partners PrEP Study). Monthly measures were assessed for the first 6 months of follow-up. Results: One thousand, one hundred and forty-seven participants contributed 6048 person-months of data to this analysis. Median adherence was high: self-reported rating (90%), self-reported frequency (93%), and self-reported percentage (97%); UPC (99%); and electronic monitoring (97%). Prevalence of steady-state daily dosing (SSDD; ≥40ng/ml) was 74% in a random subset of tenofovir samples obtained from 365 participants. Discrimination of SSDD versus less than SSDD levels was poor for self-reported rating [area under the receiver-operating curve (AROC) 0.54], self-reported frequency (AROC 0.52), self-reported percentage (AROC 0.56) and UPC (AROC 0.58), but moderate for electronic monitoring (AROC 0.70). Correlation was moderate among self-reported measures, adherence (0.61-0.66), but low for these self-reported measures compared with UPC (0.32-0.36) and with electronic monitoring (0.22-0.28). Conclusion: Electronic monitoring was the only adherence measure with meaningful ability to discriminate between SSDD and less than SSDD plasma tenofovir levels. Correlation between subjective and objective measures was poor. Future research should explore novel approaches to adherence measurement as PrEP moves into demonstration projects and programmatic implementation.

AB - Background: Preexposure prophylaxis (PrEP) efficacy is highly dependent on adherence. Yet, it is unclear which adherence measures perform best for PrEP. Methods: We compared three types of self-reported adherence questions (rating of ability to adhere, frequency of doses taken, percentage of doses taken) and three forms of objective adherence measurement [unannounced pill counts (UPC), electronic monitoring, plasma tenofovir levels] using data from an ancillary adherence study within a clinical trial of PrEP among East African serodiscordant couples (Partners PrEP Study). Monthly measures were assessed for the first 6 months of follow-up. Results: One thousand, one hundred and forty-seven participants contributed 6048 person-months of data to this analysis. Median adherence was high: self-reported rating (90%), self-reported frequency (93%), and self-reported percentage (97%); UPC (99%); and electronic monitoring (97%). Prevalence of steady-state daily dosing (SSDD; ≥40ng/ml) was 74% in a random subset of tenofovir samples obtained from 365 participants. Discrimination of SSDD versus less than SSDD levels was poor for self-reported rating [area under the receiver-operating curve (AROC) 0.54], self-reported frequency (AROC 0.52), self-reported percentage (AROC 0.56) and UPC (AROC 0.58), but moderate for electronic monitoring (AROC 0.70). Correlation was moderate among self-reported measures, adherence (0.61-0.66), but low for these self-reported measures compared with UPC (0.32-0.36) and with electronic monitoring (0.22-0.28). Conclusion: Electronic monitoring was the only adherence measure with meaningful ability to discriminate between SSDD and less than SSDD plasma tenofovir levels. Correlation between subjective and objective measures was poor. Future research should explore novel approaches to adherence measurement as PrEP moves into demonstration projects and programmatic implementation.

KW - adherence

KW - drug levels

KW - East Africa

KW - objective adherence

KW - preexposure prophylaxis

KW - serodiscordant

KW - subjective adherence

KW - tenofovir

UR - http://www.scopus.com/inward/record.url?scp=84954499825&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954499825&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000001024

DO - 10.1097/QAD.0000000000001024

M3 - Article

VL - 30

SP - 1121

EP - 1129

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 7

ER -